Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurons | 20 | 2025 | 1935 | 1.780 |
Why?
|
| Pro-Opiomelanocortin | 10 | 2021 | 94 | 1.620 |
Why?
|
| Hypothalamus | 6 | 2024 | 217 | 1.480 |
Why?
|
| Obesity | 12 | 2024 | 2233 | 1.280 |
Why?
|
| Feeding Behavior | 8 | 2024 | 707 | 1.170 |
Why?
|
| Nuclear Receptor Coactivator 1 | 3 | 2019 | 242 | 1.110 |
Why?
|
| Sirtuin 3 | 4 | 2014 | 34 | 1.090 |
Why?
|
| Estrogen Receptor alpha | 9 | 2025 | 454 | 1.040 |
Why?
|
| Estrogens | 8 | 2018 | 512 | 0.920 |
Why?
|
| Energy Metabolism | 7 | 2021 | 773 | 0.850 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 5 | 2024 | 41 | 0.850 |
Why?
|
| Overnutrition | 1 | 2021 | 14 | 0.780 |
Why?
|
| Serotonin | 6 | 2024 | 232 | 0.770 |
Why?
|
| Fasting | 2 | 2021 | 300 | 0.720 |
Why?
|
| Melanocortins | 1 | 2020 | 12 | 0.710 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2021 | 201 | 0.690 |
Why?
|
| Mice | 35 | 2025 | 17546 | 0.600 |
Why?
|
| Body Weight | 8 | 2020 | 1003 | 0.520 |
Why?
|
| Animals | 37 | 2025 | 33837 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 20 | 2025 | 4361 | 0.450 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 32 | 0.420 |
Why?
|
| HEK293 Cells | 4 | 2022 | 738 | 0.410 |
Why?
|
| Dopamine | 2 | 2024 | 284 | 0.390 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2397 | 0.370 |
Why?
|
| NAD | 1 | 2009 | 48 | 0.340 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 73 | 0.330 |
Why?
|
| Mitochondrial Proteins | 2 | 2014 | 239 | 0.330 |
Why?
|
| Mitochondria | 2 | 2011 | 677 | 0.310 |
Why?
|
| Estradiol | 3 | 2024 | 544 | 0.300 |
Why?
|
| Homeostasis | 5 | 2020 | 682 | 0.300 |
Why?
|
| Glucose | 3 | 2023 | 880 | 0.300 |
Why?
|
| Serotonergic Neurons | 2 | 2024 | 28 | 0.290 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 5 | 2021 | 45 | 0.280 |
Why?
|
| Mice, Knockout | 7 | 2025 | 3725 | 0.260 |
Why?
|
| Eating | 5 | 2024 | 373 | 0.260 |
Why?
|
| Leptin | 2 | 2019 | 214 | 0.250 |
Why?
|
| Neural Pathways | 3 | 2024 | 265 | 0.250 |
Why?
|
| Protein Isoforms | 3 | 2011 | 408 | 0.250 |
Why?
|
| Preoptic Area | 1 | 2025 | 13 | 0.240 |
Why?
|
| Body Temperature Regulation | 1 | 2025 | 31 | 0.240 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 3 | 2024 | 20 | 0.230 |
Why?
|
| TRPC Cation Channels | 1 | 2024 | 22 | 0.230 |
Why?
|
| Hunger | 2 | 2021 | 50 | 0.230 |
Why?
|
| Chloride Channels | 1 | 2024 | 63 | 0.230 |
Why?
|
| Basal Forebrain | 1 | 2024 | 35 | 0.220 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 174 | 0.220 |
Why?
|
| Light | 1 | 2024 | 175 | 0.220 |
Why?
|
| Habenula | 1 | 2024 | 45 | 0.220 |
Why?
|
| Ventral Tegmental Area | 3 | 2021 | 50 | 0.220 |
Why?
|
| Depression, Postpartum | 1 | 2024 | 50 | 0.220 |
Why?
|
| Benzazepines | 2 | 2021 | 64 | 0.220 |
Why?
|
| Postpartum Period | 1 | 2025 | 214 | 0.210 |
Why?
|
| Agouti-Related Protein | 3 | 2021 | 42 | 0.210 |
Why?
|
| Genetic Variation | 2 | 2020 | 1479 | 0.210 |
Why?
|
| Receptors, Estrogen | 2 | 2016 | 791 | 0.200 |
Why?
|
| Satiety Response | 1 | 2021 | 32 | 0.190 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 273 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2023 | 191 | 0.190 |
Why?
|
| Sex Characteristics | 3 | 2018 | 314 | 0.190 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 2 | 2023 | 30 | 0.180 |
Why?
|
| Weight Gain | 2 | 2021 | 401 | 0.180 |
Why?
|
| Memory | 1 | 2024 | 363 | 0.180 |
Why?
|
| Dopaminergic Neurons | 2 | 2022 | 48 | 0.180 |
Why?
|
| Membrane Potentials | 2 | 2019 | 304 | 0.180 |
Why?
|
| Signal Transduction | 5 | 2021 | 4499 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 185 | 0.170 |
Why?
|
| Neuropeptide Y | 2 | 2016 | 36 | 0.170 |
Why?
|
| Dorsal Raphe Nucleus | 3 | 2024 | 23 | 0.170 |
Why?
|
| Anhedonia | 1 | 2019 | 30 | 0.170 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 163 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 365 | 0.160 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 162 | 0.160 |
Why?
|
| Feeding and Eating Disorders | 1 | 2019 | 70 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 122 | 0.150 |
Why?
|
| Male | 15 | 2024 | 60310 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4297 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2021 | 373 | 0.150 |
Why?
|
| Cell Line | 3 | 2015 | 2772 | 0.140 |
Why?
|
| Weight Loss | 1 | 2021 | 481 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 765 | 0.140 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2016 | 13 | 0.140 |
Why?
|
| Alleles | 2 | 2019 | 1603 | 0.140 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2016 | 28 | 0.140 |
Why?
|
| Heterozygote | 1 | 2019 | 678 | 0.140 |
Why?
|
| Bulimia | 1 | 2016 | 15 | 0.130 |
Why?
|
| Blood Glucose | 2 | 2023 | 1122 | 0.130 |
Why?
|
| Phenols | 2 | 2015 | 58 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2018 | 399 | 0.130 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 75 | 0.130 |
Why?
|
| Apolipoprotein A-V | 1 | 2015 | 20 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2019 | 792 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 26 | 0.130 |
Why?
|
| Corticomedial Nuclear Complex | 1 | 2015 | 4 | 0.130 |
Why?
|
| Amygdala | 1 | 2016 | 81 | 0.130 |
Why?
|
| Female | 18 | 2025 | 65598 | 0.120 |
Why?
|
| Models, Biological | 1 | 2020 | 1449 | 0.120 |
Why?
|
| Anxiety | 1 | 2021 | 961 | 0.120 |
Why?
|
| Protein Binding | 2 | 2024 | 1741 | 0.120 |
Why?
|
| Reproduction | 1 | 2016 | 243 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2019 | 848 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2019 | 556 | 0.120 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 126 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 340 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2018 | 809 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 258 | 0.110 |
Why?
|
| Pyrazoles | 2 | 2015 | 305 | 0.110 |
Why?
|
| Humans | 10 | 2024 | 123254 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 103 | 0.110 |
Why?
|
| Piperazines | 1 | 2015 | 230 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 216 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 165 | 0.100 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2024 | 58 | 0.100 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3286 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2014 | 369 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2015 | 464 | 0.100 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Half-Life | 1 | 2011 | 156 | 0.090 |
Why?
|
| Protein Stability | 1 | 2011 | 166 | 0.090 |
Why?
|
| Depression | 1 | 2019 | 1228 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 98 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2011 | 171 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2015 | 644 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 261 | 0.090 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 66 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 114 | 0.080 |
Why?
|
| Acetylation | 1 | 2009 | 166 | 0.080 |
Why?
|
| Diet, High-Fat | 2 | 2024 | 211 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 367 | 0.080 |
Why?
|
| Phenotype | 1 | 2019 | 4227 | 0.080 |
Why?
|
| Cattle | 1 | 2009 | 562 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2815 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 623 | 0.080 |
Why?
|
| Diet | 1 | 2015 | 1136 | 0.070 |
Why?
|
| RNA Interference | 1 | 2009 | 496 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 1284 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 614 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 767 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2525 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2009 | 1070 | 0.070 |
Why?
|
| Peptides | 1 | 2009 | 791 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 510 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2695 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2024 | 45 | 0.060 |
Why?
|
| Enkephalins | 1 | 2024 | 20 | 0.060 |
Why?
|
| Darkness | 1 | 2024 | 29 | 0.060 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2015 | 68 | 0.060 |
Why?
|
| Body Temperature | 1 | 2025 | 110 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3867 | 0.060 |
Why?
|
| Optogenetics | 1 | 2024 | 57 | 0.060 |
Why?
|
| GABAergic Neurons | 1 | 2024 | 63 | 0.060 |
Why?
|
| Oxytocin | 1 | 2024 | 70 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2024 | 66 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2024 | 149 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 2016 | 269 | 0.060 |
Why?
|
| Anoctamins | 1 | 2023 | 15 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 72 | 0.050 |
Why?
|
| Anorexia | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2022 | 42 | 0.050 |
Why?
|
| Nerve Net | 1 | 2024 | 238 | 0.050 |
Why?
|
| Appetite | 1 | 2021 | 36 | 0.050 |
Why?
|
| Time | 1 | 2021 | 94 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2020 | 182 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2020 | 269 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 461 | 0.040 |
Why?
|
| Pregnancy | 2 | 2025 | 7128 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 819 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 42 | 0.040 |
Why?
|
| Rats | 1 | 2024 | 3664 | 0.040 |
Why?
|
| Endocrinology | 1 | 2020 | 141 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 2016 | 29 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 70 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2016 | 46 | 0.030 |
Why?
|
| Fluoxetine | 1 | 2016 | 43 | 0.030 |
Why?
|
| Corticosterone | 1 | 2016 | 59 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2016 | 123 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 126 | 0.030 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2015 | 15 | 0.030 |
Why?
|
| Bicuculline | 1 | 2015 | 21 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2015 | 67 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2015 | 50 | 0.030 |
Why?
|
| GABA Agents | 1 | 2015 | 21 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 105 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2015 | 24 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2015 | 122 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 78 | 0.030 |
Why?
|
| Valine | 1 | 2015 | 106 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 230 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 433 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2015 | 96 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 130 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 5 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2014 | 18 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 701 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 383 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 79 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 393 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1265 | 0.030 |
Why?
|
| Superoxides | 1 | 2014 | 154 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 113 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 967 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 569 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1102 | 0.030 |
Why?
|
| Action Potentials | 1 | 2016 | 501 | 0.030 |
Why?
|
| Ion Channels | 1 | 2014 | 188 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 330 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 381 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 466 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 522 | 0.020 |
Why?
|
| Echocardiography | 1 | 2016 | 1049 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1688 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 483 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1611 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1326 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 816 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 5765 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24263 | 0.010 |
Why?
|